ft.com WASHINGTON, United States -- Pfizer announced Tuesday it was seeking US authorization for COVID booster shots among adolescents aged 16 and 17, as concerns grow about the impact of the new Omicron variant. The Food and Drug Administration (FDA) has so far only granted emergency use...